The Consumer Product Safety Program of Health Canada wishes to introduce a new approach to communicate with stakeholders about its compliance and enforcement activities under the General Prohibition provisions of the Canada Consumer Product Safety Act (CCPSA). At the webinar, we will be seeking your comments on this proposed approach and outline the benefits of this approach along with industry’s responsibilities.
General Prohibition: As set out in sections 7(a) and 8(a) of the CCPSA, General Prohibition, broadly speaking, prohibits anyone from manufacturing, importing, advertising or selling a product in Canada that poses a danger to human health or safety. It applies to all consumer products and is fundamental to the purpose of the CCPSA, which is to protect the public by preventing and addressing dangers to human health or safety posed by consumer products in Canada.
Who should attend?
Industry and associations are invited to participate in this consultation.
When?
English session: Friday, August 17, 2018 at 1:00 pm (EDT) Eastern Daylight Time
French session: Monday, August 20, 2018 at 1:00 pm (EDT) Eastern Daylight Time
How do I register?
To register, please e-mail us at: hc.ccpsa-lcspc.sc@canada.ca and indicate which session (French or English) you would like to attend.
Registration will take place on a first come, first serve basis. If interest exceeds the webinar capacity, additional webinars will be planned for a later date.
Detailed information on how to connect to the webinar will be e-mailed to you prior to the date of webinar.
Other questions?
If you have any questions, please email us at: hc.ccpsa-lcspc.sc@canada.ca